Aligos Therapeutics, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
ALGS$3.95-2.9%Stored close · as of Nov 9, 2026
What changed in Risk Factors?
Read the current filingComparison unavailable
The comparison is taking longer than usual or could not load. Reload to try again, or open the filing text.
Unavailable is not the same as unchanged.